Najat Khan, CEO, opened by stating that Recursion is at an important inflection point, harnessing its integrated AI-driven platform to "translate insights into evidence; evidence that this platform, ...

Hi, friends, being AI enthusiast, I'm an MBA, CEO and CPO who loves building products. I share my insights here.) Hi, friends, being AI enthusiast, I'm an MBA, CEO and CPO who loves building products.

The ability to write parts of SQL queries in natural language will help developers speed up their work, analysts say. Google is previewing a new AI-driven feature in its BigQuery data warehouse that ...

Following an investigation by The Guardian that found Google AI Overviews offering misleading information in response to certain health-related queries, the company appears to have removed the AI ...

Abstract: SQL:1999 recursive queries are almost a quarter century old. In this standard the recursive queries have the form of recursive common table expressions. In recent years vendors of almost all ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals currently has the industry's largest AI supercomputer. It also has partnerships with major drugmakers, but these have yet to yield major wins. Recursion'a lack of clinical ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion Pharmaceuticals stock jumped 16% on October 8, 2025, reaching around $6.08 after falling 5.4% the previous day on broader market weakness. The company reported Q2 2025 revenue of $19.2 ...